SEC Form 4 · accession 0001654954-17-007775

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 17, 2017

Accepted (ET)

Aug 21, 2017 · 7:43 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410098

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 17, 2017	P	80,000	$0.398	A	180,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Common Stock)^F2	$2.24	holding	—	—	—	—	Feb 21, 2027	Common Stock	40,000	40,000	D
Restricted Stock Units^F3	—	holding	—	—	—	—	—	Common Stock	10,000	10,000	D
Stock Option (Right to Buy Common Stock)^F4	$4.28	holding	—	—	—	—	Apr 28, 2026	Common Stock	50,000	50,000	D

F1This transaction was executed in multiple trades at prices ranging from $0.380 to $0.410. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2These options were granted on 2/21/2017. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F3The restricted stock units were granted on February 21, 2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F4These options were granted on 4/28/2016. These options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.